(36 days)
The Stryker Steri-Shield Flyte Toga, Pullover; Stryker Steri-Shield Flyte Toga, Zippered; Stryker Steri-Shield Flyte Toga with Peel-away Lens, Zippered; and Stryker Steri-Shield Flyte Togas with UV Lens, Zippered are components of a personal protection system and are intended to protect the patient, health care personnel and operating room personnel against contamination, exposure of infectious bodily fluids, the transfer of microorganisms and particulate material.
The scope of this Special 510k material modification is limited to material changes to the gown. The toga has a hood and gown section. The hood covers the user's head. A lens is attached to the front of the hood. The gown of the toga covers the user's front, back and arms. The Stryker Steri-Shield Flyte Togas are tested to meet applicable AAMI PB70:2003 standards. The AAMI standard does not cover apparel for the head, face, and eyes. Therefore, the hoods and lens (components of the togas) are exempt from classification under the AAMI PB70:2003 standard.
Stryker Steri-Shield Flyte Toga, Pullover: The Stryker Steri-Shield Flyte Toga, Pullover is intended to be worn over any Stryker Flyte Helmet. The Stryker Steri-Shield Flyte Pullover togas provide Level 4 and Level 1 barrier protection for the critical zones as set froth in the accompanying drafted IFUs (Attachment 8 and as classified under the AAMI (Association for the Advancement of Medical Instrumentation) guidelines for barrier performance. This garment was tested for resistance to bacteriophage Phi-X174 in accordance with ASTM F1671:2003 per the AAMI Barrier Classification System and demonstrate a passing result with an AQL of 4% under Procedure A. Level 1 zones resist liquid penetration per AATCC (American Association of Textile Chemist and Colorist) 42:2000 with an AQL (acceptable quality level) of 4%. Level 4 critical zones resist liquid and viral penetration. The Stryker Steri-Shield Flyte Toga Zippered garment was tested for resistance to bacteriophage Phi-X174 in accordance with ASTM (American Society for Testing and Materials) F1671:2003 with an AQL of 4% under Procedure A. The barrier material for the Stryker Steri-Shield Flyte Toga Pullover is constructed of layers of polypropylene or polyester non-woven fabric and copolymer polyester film. The Stryker Steri-Shield Flyte Toga, Pullover will be available in a variety of sizes ranging from Small/Medium thru 3X-Large sizes.
Stryker Steri-Shield Flyte Toga, Zippered: Stryker Steri-Shield Flyte Toga with Peel-away Lens, Zippered; Stryker Steri-Shield Flyte Toga with UV Lens, Zippered. The Stryker Steri-Shield Flyte Toga, Zippered; Stryker Steri-Shield Flyte Toga with Peel-away Lens, Zippered; and Stryker Steri-Shield Flyte Togas with UV Lens. Zippered are intended to be worn over any Stryker Flyte Helmet. The Stryker Steri-Shield Flyte Togas provide protection as specified by the AAMI (Association for the Advancement of Medical Instrumentation) Barrier Classification System. Level 1 zones resist liquid penetration per AATCC (American Association of Textile Chemist and Colorist) 42:2000 with an AQL (acceptable quality level) of 4%. Level 4 critical zones resist liquid and viral penetration. The Stryker Steri-Shield Flyte Toga Zippered garment was tested for resistance to bacteriophage Phi-X174 in accordance with ASTM (American Society for Testing and Materials) F1671:2003 with an AQL of 4% under Procedure A. The Level 4 barrier material is constructed of layers of polypropylene or polyester non-woven fabric and copolymer polyester film. The Level 1 material on the back of the zippered togas is constructed of 35 gram SMMS polypropylene. The Stryker Steri-Shield Flyte Toga. Zippered will be available in a variety of sizes ranging from Small/Medium thru 3X-Large sizes.
The provided text describes a 510(k) submission for Stryker Steri-Shield Flyte Togas, which are surgical gowns. The focus of the submission is on material changes to existing products and demonstrating substantial equivalence to predicate devices, rather than a study on a new device's performance against specific acceptance criteria in a clinical setting.
Therefore, many of the requested categories for AI/medical device studies (e.g., sample size for test set, number of experts for ground truth, MRMC study, stand-alone performance) are not applicable to this document as it's not a clinical trial of an AI-powered diagnostic or therapeutic device.
However, I can extract information related to the performance standards and testing mentioned for the Steri-Shield Flyte Togas.
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria (Standard) | Reported Device Performance |
|---|---|
| AAMI PB70:2003 standards (General) | The Stryker Steri-Shield Flyte Togas are tested to meet applicable AAMI PB70:2003 standards. (Note: The AAMI standard does not cover apparel for the head, face, and eyes; therefore, hoods and lenses are exempt). |
| AAMI Barrier Classification System - Level 1 (liquid penetration) | Level 1 zones resist liquid penetration per AATCC 42:2000 with an AQL (acceptable quality level) of 4%. The barrier material for the Pullover and the Level 1 material on the back of the zippered togas are constructed of 35 gram SMMS polypropylene. |
| AAMI Barrier Classification System - Level 4 (liquid and viral penetration) | Level 4 critical zones resist liquid and viral penetration. Tested for resistance to bacteriophage Phi-X174 in accordance with ASTM F1671:2003 with an AQL of 4% under Procedure A. The Level 4 barrier material for both Pullover and Zippered versions is constructed of layers of polypropylene or polyester non-woven fabric and copolymer polyester film. |
2. Sample size used for the test set and the data provenance
Not applicable. This document describes performance testing against material standards, not a clinical study with a "test set" of patient data. The AQL (Acceptable Quality Level) of 4% for certain tests refers to a sampling plan for manufacturing quality control, not a clinical test set.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. Ground truth as typically defined for AI/medical device studies (e.g., expert consensus on medical images) is not relevant here. The "ground truth" for these tests are the established and recognized testing methodologies and standards (AAMI, AATCC, ASTM).
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. No adjudication method for a clinical test set is relevant to this document.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is not an AI-powered device or a cognitive aid for human readers.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. This is not an algorithm. The device's "standalone" performance is its ability to meet the defined material barrier standards.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The "ground truth" or reference standards used are established industry and regulatory standards for material performance:
- AAMI PB70:2003 (Association for the Advancement of Medical Instrumentation)
- AATCC 42:2000 (American Association of Textile Chemist and Colorist) for liquid penetration
- ASTM F1671:2003 (American Society for Testing and Materials) for resistance to viral penetration (bacteriophage Phi-X174).
8. The sample size for the training set
Not applicable. There is no concept of a "training set" for this type of device and testing.
9. How the ground truth for the training set was established
Not applicable.
{0}------------------------------------------------
K07 3017
4100 E. Milham Avenue
Kalamazoo, MI 49001
t: 269 323 7700 ff: 800 965 6505
www.stryker.com
NOV 3 0 2007
Image /page/0/Picture/3 description: The image shows the word "stryker" in a bold, sans-serif font. The word is all lowercase, and there is a registered trademark symbol to the upper right of the letter "r". The word is in black and the background is white.
Instruments
510(k) Summary
| Device Sponsor: | Stryker Instruments4100 East Milham AvenueKalamazoo, Michigan 49001(p) 269-323-7700(f) 269-324-5412 |
|---|---|
| Registration No.: | 1811755 |
| Trade Name: | Stryker Steri-Shield Flyte Togas |
| Classification: | Sterile Surgical Gowns |
| Equivalent to: | K0063005-Stryker T6 Hoods and Togas |
| Device Description: | Device History |
| Summary of Stryker Steri-Shield Flyte Togas | |
| The scope of this Special 510k material modification is limitedto material changes to the gown. The toga has a hood and gownsection. The hood covers the user's head. A lens is attached to thefront of the hood. The gown of the toga covers the user's front,back and arms. The Stryker Steri-Shield Flyte Togas are tested tomeet applicable AAMI PB70:2003 standards. The AAMI standarddoes not cover apparel for the head, face, and eyes. Therefore, thehoods and lens (components of the togas) are exempt fromclassification under the AAMI PB70:2003 standard. | |
| Stryker Steri-Shield Flyte Toga, Pullover | |
| The Stryker Steri-Shield Flyte Toga, Pullover is intended to beworn over any Stryker Flyte Helmet. The Stryker Steri-ShieldFlyte Pullover togas provide Level 4 and Level 1 barrier protectionfor the critical zones as set froth in the accompanying drafted IFUs(Attachment 8 and as classified under the AAMI (Association forthe Advancement of Medical Instrumentation) guidelines forbarrier performance. This garment was tested for resistance tobacteriophage Phi-X174 in accordance with ASTM F1671:2003 |
{1}------------------------------------------------
KITT
per the AAMI Barrier Classification System and demonstrate a passing result with an AQL of 4% under Procedure A. Level 1 zones resist liquid penetration per AATCC (American Association of Textile Chemist and Colorist) 42:2000 with an AQL (acceptable quality level) of 4%. Level 4 critical zones resist liquid and viral penetration. The Stryker Steri-Shield Flyte Toga Zippered garment was tested for resistance to bacteriophage Phi-X174 in accordance with ASTM (American Society for Testing and Materials) F1671:2003 with an AQL of 4% under Procedure A. The barrier material for the Stryker Steri-Shield Flyte Toga Pullover is constructed of layers of polypropylene or polyester non-woven fabric and copolymer polyester film. The Stryker Steri-Shield Flyte Toga, Pullover will be available in a variety of sizes ranging from Small/Medium thru 3X-Large sizes.
Stryker Steri-Shield Flyte Toga, Zippered: Stryker Steri-Shield Flyte Toga with Peel-away Lens, Zippered; Stryker Steri-Shield Flyte Toga with UV Lens, Zippered.
The Stryker Steri-Shield Flyte Toga, Zippered; Stryker Steri-Shield Flyte Toga with Peel-away Lens, Zippered; and Stryker Steri-Shield Flyte Togas with UV Lens. Zippered are intended to be worn over any Stryker Flyte Helmet. The Stryker Steri-Shield Flyte Togas provide protection as specified by the AAMI (Association for the Advancement of Medical Instrumentation) Barrier Classification System. Level 1 zones resist liquid penetration per AATCC (American Association of Textile Chemist and Colorist) 42:2000 with an AQL (acceptable quality level) of 4%. Level 4 critical zones resist liquid and viral penetration. The Stryker Steri-Shield Flyte Toga Zippered garment was tested for resistance to bacteriophage Phi-X174 in accordance with ASTM (American Society for Testing and Materials) F1671:2003 with an AQL of 4% under Procedure A. The Level 4 barrier material is constructed of layers of polypropylene or polyester non-woven fabric and copolymer polyester film. The Level 1 material on the back of the zippered togas is constructed of 35 gram SMMS polypropylene. The Stryker Steri-Shield Flyte Toga. Zippered will be available in a variety of sizes ranging from Small/Medium thru 3X-Large sizes.
Indications for Use: The Stryker Steri-Shield Flyte Togas are components of a personal protection system and are intended to protect the patient, health care personnel and operating room personnel against
{2}------------------------------------------------
ー…( 다.
각자
| contamination, exposure of infectious bodily fluids, the transfer ofmicroorganisms and particulate material. | ||
|---|---|---|
| Substantial Equivalence(SE) Rational: | The Stryker Steri-Shield Flyte Togas are substantially equivalent todevices in commercial distribution. | |
| Stryker Steri-Shield Flyte Togas have an equivalent intended use,patient contact materials, operating principles and physicalspecifications as compared to predicate devices. | ||
| Safety and Effectiveness: | Based upon the comparison to the predicate devices, the StrykeSteri-Shield Flyte Togas are substantially equivalent to legallymarketed devices. The Stryker Steri-Shield Flyte Togas do notraise any new safety or efficacy concerns. | |
| Submitted by: | Paulette D. JohnsonRegulatory AnalystStryker Instruments4100 East Milham AvenueKalamazoo, MI 49009p: 269-323-7700, ext 3084f: 269-324-5412 |
tourities Signature
Date Submitted:
10-18-07
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three lines representing its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 3 0 2007
Ms. Paulette D. Johnson Regulatory Analyst Stryker Instruments 4100 East Milham Avenue Kalamazoo, Michigan 49001
Re: K073017
Trade/Device Name: Stryker Steri-Shield Flyte Togas Regulation Number: 21 CFR 878.4040 Regulation Name: Surgical Apparel Regulatory Class: II Product Code: FYA Dated: November 19, 2007 Received: November 20, 2007
Dear Ms. Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
Page 2 - Ms. Johnson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Clue
Chia-Lin Pi, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Indications for Use
510(k) Number (if known): K073017
Device Name: Stryker Steri-Shield Flyte Togas (Stryker Steri-Shield Flyte Toga, Pullover; Stryker Steri-Shield Flyte Toga, Zippered; Stryker Steri-Shield Flyte Toga with Peel-away Lens, Zippered; and Stryker Steri-Shield Flyte Togas with UV Lens, Zippered)
Indications for Use:
The Stryker Steri-Shield Flyte Toga, Pullover; Stryker Steri-Shield Flyte Toga, Zippered; Stryker Steri-Shield Flyte Toga with Peel-away Lens, Zippered; and Stryker Steri-Shield Flyte Togas with UV Lens, Zippered are components of a personal protection system and are intended to protect the patient, health care personnel and operating room personnel against contamination, exposure of infectious bodily fluids, the transfer of microorganisms and particulate material.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
S. H. Murphy, Jr.
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: _
Page 1 of 1
§ 878.4040 Surgical apparel.
(a)
Identification. Surgical apparel are devices that are intended to be worn by operating room personnel during surgical procedures to protect both the surgical patient and the operating room personnel from transfer of microorganisms, body fluids, and particulate material. Examples include surgical caps, hoods, masks, gowns, operating room shoes and shoe covers, and isolation masks and gowns. Surgical suits and dresses, commonly known as scrub suits, are excluded.(b)
Classification. (1) Class II (special controls) for surgical gowns and surgical masks. A surgical N95 respirator or N95 filtering facepiece respirator is not exempt if it is intended to prevent specific diseases or infections, or it is labeled or otherwise represented as filtering surgical smoke or plumes, filtering specific amounts of viruses or bacteria, reducing the amount of and/or killing viruses, bacteria, or fungi, or affecting allergenicity, or it contains coating technologies unrelated to filtration (e.g., to reduce and or kill microorganisms). Surgical N95 respirators and N95 filtering facepiece respirators are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9, and the following conditions for exemption:(i) The user contacting components of the device must be demonstrated to be biocompatible.
(ii) Analysis and nonclinical testing must:
(A) Characterize flammability and be demonstrated to be appropriate for the intended environment of use; and
(B) Demonstrate the ability of the device to resist penetration by fluids, such as blood and body fluids, at a velocity consistent with the intended use of the device.
(iii) NIOSH approved under its regulation.
(2) Class I (general controls) for surgical apparel other than surgical gowns and surgical masks. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9.